Cynapsus Therapeutics Inc. (CYNA): OrbiMed Advisors Adds To Its Stake

Page 5 of 7 – SEC Filing
CUSIP No. 23257Y859
SCHEDULE 13G
Page 5 of 7 Pages
Item 1.
(a) Name of Issuer:
Cynapsus Therapeutics Inc.
 
(b) Address of Issuer’s Principal Executive Offices:
828 Richmond Street West
Toronto, Ontario M6J 1C9
Canada
Item 2.
(a) Name of Person Filing:
This Schedule 13G is being filed by each of the following persons (each a “Reporting Person”, and together, the “Reporting Persons”):
 
(i)
OrbiMed Capital GP V LLC (“GP V”)
 
(ii)
OrbiMed Advisors LLC (“Advisors”)
 
(iii)
Samuel D. Isaly (“Isaly”)
 
(b) Address of Principal Business Office:
601 Lexington Avenue, 54th Floor
New York, NY 10022
 
(c) Citizenship:
Please refer to Item 4 on each cover sheet for each filing person.
 
(d) Title of Class of Securities:
Common Stock
 
(e) CUSIP No.:
23257Y859
 

Follow Cynapsus Therapeutics Inc.